Ion Dx
CA - MontereyBiotechnology
Focus: Ion Dx develops ion mobility spectrometry technology and associated diagnostic services for biotech applications. The company operates as a public-stage biotech focused on analytical instrumentation rather than therapeutic development.
Profile data last refreshed 4h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
63+63 this month
Hot — 95 jobs added in 30d
Net +63 (95 new, 32 removed). Aggressive expansion phase.
Should You Work at Ion Dx?
AI assessmentIon Dx is a high-risk, early-stage venture with technological promise but unproven commercial viability; only pursue if you accept pre-revenue biotech risk and have conviction in ion mobility adoption.
Why Work Here
- Early-stage public company with potential upside if ion mobility technology gains traction in pharma/biotech workflows
- Opportunity to shape a new analytical platform category with foundational IP and instrumentation focus
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Ion Dx
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.